Bhadra.biz

BHADRA PHARMA CARE
O u r ph a r m a c e u t i c a l m a n u f a c t u r i n g pla n t is eq u i p p e d wit h m o d e r n hig h- sp e e d m a c h i n e s an d inte g r a t e d pa c k a g i n g line s to be co s t effi ci e n t. Ext e n s i v e us e of vis u a l ins p e c t i o n m a c h i n e s , m u l ti- stati o n ta bl e t pr e s s e s , attr a c t i v e pri m a r y pa c k i n g , liq ui d m a n u f a c t u r i n g an d fillin g line s are so m e of th e ex a m p l e s . T h e pla n t wit h hig h ca p a c i t i e s an d sc o p e for fut u r e ex p a n s i o n is ca p a b l e of m a n u f a c t u r i n g all ph a r m a c e u t i c a l do s a g e (Al o p a t h i c as w e ll as Ay u r v e d i c) for m s viz. tabl e t s, ca p s u l e s , or al liq ui d, ext e r n a l liq ui d, dr y syr u p, oint m e n t s , cre a m , lotio n s , gel s, etc.
Anti Depressants:
Sr. NO Molecules
Dosage Forms
Strength
Anti - Convulsants :
Sr. NO Molecules
Dosage Forms
Strength
P h e n o b a r b i t o n e & A m y l o b a r b i t o n e P h e n o b a r b i t o n e & A m y l o b a r b i t o n e S yr u p 1 0 0 m g + P h e n o b a r b i t o n e 30 m g Anti – Asthamatics:
Sr. NO Molecules
Dosage Forms
Strength
Antacids:
Sr. NO Molecules
Dosage Forms
Strength
Al 400 m g + M g H y d r o x i d e 400 m g (Al 200 m g + M g 200 m g)/5 ml - 1 5 0 m l Diuretics:
Sr. NO Molecules
Dosage Forms
Strength
Erectile Dysfunction:
Sr. NO Molecules
Dosage Forms
Strength
Drugs Acting on Urethra & Vagina:
Sr. NO Molecules
Dosage Forms
Strength
6's, 1 5 g G el 1 % (Eac h), 30 g G e l 2 % w/w tu b e Topical Infectives:
Sr. N O M o l e c u l e s
Anti - Diabetics & Hyperglycaemics:
Sr. NO Molecules
Dosage Forms
Strength
80 m g + R o s i g l i t a z o n e 2 m g 400 m g + Gli b e n c l a m i d e 2.5 m g ,500 m g + Gli b e n c l a m i d e 5 m g,400 m g + Gli p i z i d e 2.5 m g , 500 m g+ Gli p i z i d e 5 m g , 500 m g +Gli cl a z i d e 80 m g , 10 0 0 m g +Gli m e p r i d e 2 m g Ta b l e t s m , 5 0 0 m g+ R o s i g l it a z o n e 2 m g Ta b l e t s Anaesthetics:
Sr. N O M o l e c u l e s
Other Drugs:
Sr. N O M o l e c u l e s
Anti - Psychotics & Antmanics:
Sr. N O M o l e c u l e s
Anti - Hypertensive Drugs:
Sr. N O M o l e c u l e s
Lisi n o p r i l 5 m g , 2.5 m g + Lo s a r t a nP ot a s s i u m 25 m g Urinary Anti – Infectives:
Sr. N O M o l e c u l e s
Di s o d i u m H y d r o g e n Citr a t e 0.62 5 g + D i p o t H y d r o g e n Cit. 0.62 5 g/5 m l - 10 0 m l Anti -Ulcer & Anti - Secretory Drugs:
Sr. N O M o l e c u l e s
1 g m / 5 ml - 10 0 m l , 1 g m / 5 ml - 200 m l Lo p e r a m i d e + Fur a z o l i d o n e M e t r o n i d a z o l e 1 0 0 m g + N a l i d i x i c Aci d M e t r o n i d a z o l e 200 m g + N o r fl o x a c i n M e t r o n i d a z o l e 10 0 m g + N o r fl o x a c i n M e t r o n i d a z o l e 10 0 m g + N o r fl o x a c i n Ti ni d a z o l e 600 m g + C i p r o f l o x a c i n Ti ni d a z o l e 600 m g + O f l o x a c i n M e t r o n i d a z o l e 10 0 m g + O f l o x a c i n Or n i d a z o l e 500 m g + O f l o x a c i n (Withania Somnifera)Reference : Ayurbhisek Care Medicated Skin Guard OintmentBadam Oil Care Vesoline(For external use only)COMPOSITION :Badam Tel Demotax OintmentCOMPOSITION :Tankan Amla 10% AB Salicylic Acid 10% RTS Part I Kapoor Baras 1% AB Parrafin Base Q.S. Enzo effervescent GranulesCOMPOSITION :Jambiramla 45% AB 342 Sverjika 54% AB 624 Flavoured Excipients Q.S. Vapo-Care Medicated Vaporising Rubbing Ointment

Source: http://www.bhadra.biz/other-files/product-list.pdf

Microsoft word - fbfacteursderisque7mars06cam.doc

L’épidémiologie et les facteurs de risque chez les enfants atteints du trouble déficitaire d’attention avec ou sans hyperactivité : résultats préliminaires 1 1. Cameron Montgomery , Ph.D. Faculté d'éducation-Faculty of Education Université d'Ottawa-University of Ottawa 145, rue Jean-Jacques-Lussier-145 Jean-Jacques Lussier St. site web/web site : http://aix1.uottawa.ca/~

Wake forest

COMMENT A CONSTITUTIONAL RIGHT TO SUE MANAGED CARE ORGANIZATIONS illions of Americans rely on Managed Care Organizations M(“ MCOs”) for their health insurance, and every day MCOs make administrative decisions that deny necessary medical treatment to those in need.1 In the case of “wrongful” withholding of treatment, Americans would normally turn to the courts for help, but

Copyright © 2010-2014 Medical Articles